Trial Outcomes & Findings for Alpha as a Predictive Biomarker (NCT NCT02796625)

NCT ID: NCT02796625

Last Updated: 2021-08-11

Results Overview

The highest power of EEG-based alpha activity in the 8-12Hz frequency range, calculated using the center of gravity method.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

80 participants

Primary outcome timeframe

pain-free and pain states at the baseline visit

Results posted on

2021-08-11

Participant Flow

Participant milestones

Participant milestones
Measure
Painful Stimuli
Participants will be exposed to painful heat Painful Stimuli: warm or painful heat administration
Overall Study
STARTED
80
Overall Study
COMPLETED
61
Overall Study
NOT COMPLETED
19

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Painful Stimuli
n=61 Participants
Participants will be exposed to painful heat Painful Stimuli: warm or painful heat administration
Age, Categorical
<=18 years
0 Participants
n=61 Participants
Age, Categorical
Between 18 and 65 years
61 Participants
n=61 Participants
Age, Categorical
>=65 years
0 Participants
n=61 Participants
Age, Continuous
27.8 years
n=61 Participants
Sex: Female, Male
Female
30 Participants
n=61 Participants
Sex: Female, Male
Male
31 Participants
n=61 Participants
Region of Enrollment
United States
61 participants
n=61 Participants

PRIMARY outcome

Timeframe: pain-free and pain states at the baseline visit

Population: all participants with valid data

The highest power of EEG-based alpha activity in the 8-12Hz frequency range, calculated using the center of gravity method.

Outcome measures

Outcome measures
Measure
Painful Stimuli
n=61 Participants
Participants will be exposed to painful heat Painful Stimuli: warm or painful heat administration
Peak Alpha Frequency (Hz)
10.04 frequency (Hz)
Standard Deviation 0.20

SECONDARY outcome

Timeframe: alpha activity at pain-free and pain states, assessed at a second visit following the first visit by at least 3 week

Population: Participants with data at visits 1 and 2

Outcome measures

Outcome measures
Measure
Painful Stimuli
n=43 Participants
Participants will be exposed to painful heat Painful Stimuli: warm or painful heat administration
Alpha Wave Activity Reliability
.81 Spearman rho

Adverse Events

Painful Stimuli

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. David Seminowicz

University of Maryland Baltimore

Phone: 14107063476

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place